Anna Bergan

Anna Bergan is an accomplished clinical operations professional with extensive experience in managing global clinical studies, particularly within hematology and oncology. Currently serving as Clinical Operations Director at Oncopeptides AB since January 2020, Anna oversees a global phase 3 study, ensuring quality, budget adherence, and timely delivery by coordinating the study team. Prior roles include Clinical Operations Manager at Oncopeptides AB, Senior Clinical Research Associate at AbbVie, and various positions as Clinical Research Associate at GSK and TFS - Clinical Contract Research Organization. Anna's academic qualifications include a PhD in Molecular Biology from Karolinska Institutet and a postgraduate degree in Clinical Drug Development from Uppsala University, complemented by a Master of Science in Molecular Biology from Stockholm University.